Elisabeth I. Heath, Daniel J. George, Alton Oliver Sartor, Neal D. Shore, Jennifer Nguyen, Jeetvan Patel, Amrita Sawhney, Barinder Kang, Clare Byrne, Chris LaVallee, Xiao X. Wei. "[
                    <sup>177</sup>
                    Lu]Lu-PSMA-617 (
                    <sup>177</sup>
                    Lu-PSMA-617) in combination with an androgen receptor pathway inhibitor (ARPI) versus
                    <sup>177</sup>
                    Lu-PSMA-617 alone for the treatment of metastatic castration-resistant prostate cancer (mCRPC): A real-world prostate cancer disease observation (PRECISION) data platform analysis.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.78